Search results
Results from the WOW.Com Content Network
Leica Biosystems, founded 1872 as Precision Engineering, [1] is a medical devices company that develops and supplies clinical diagnostics to the pathology market. It is also a research, instrument, and medical device company as well as a division of Danaher Corporation .
The company's origins go back to a Massachusetts real estate investment trust organized in 1969 as DMG, Inc. In 1978, DMG, Inc. was reorganized as a Florida corporation and changed its name to Diversified Mortgage Investors, Inc. DMG had been invested in retirement home developments when it was taken over by the Rales brothers, and in 1984, the company adopted the name Danaher and ...
Leica Microsystems GmbH is a German microscope manufacturing company. It is a manufacturer of optical microscopes , equipment for the preparation of microscopic specimens and related products. There are ten plants in eight countries with distribution partners in over 100 countries.
LEXINGTON, Mass., Dec. 18, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ: TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced the sale of four T2Dx ® Instruments to its European (EU) distributor that represents multiple EU counties, demonstrating commercial expansion and increased international market penetration.
(The Center Square) – A bipartisan group of U.S. senators has reintroduced legislation to push the Food and Drug Administration to adopt modern alternatives to animal testing. The bill would ...
Leica Camera AG (/ ˈ l aɪ k ə /) is a German company that manufactures cameras, optical lenses, photographic lenses, binoculars, and rifle scopes.The company was founded by Ernst Leitz in 1869 (Ernst Leitz Wetzlar), in Wetzlar, Germany.
The Internal Revenue Service on Thursday began laying off more than 6,000 new and newly promoted employees across the country, sources familiar with the planning told ABC News, as part of ...
On the occasion of the 10th anniversary of the Frida relaunch in the U.S., CEO Chelsea Hirschhorn looks back at the "blind naivete" that let her believe the snotsucker could go mainstream.